Standout Papers

Glucagon-Like Peptide 1 Receptor Agonists for Type 2 Diabetes 2017 2026 2020 2023 278
  1. Glucagon-Like Peptide 1 Receptor Agonists for Type 2 Diabetes (2017)
    Deborah Hinnen Diabetes Spectrum

Immediate Impact

1 from Science/Nature 55 standout
Sub-graph 1 of 25

Citing Papers

Efficacy and Safety of Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss Among Adults Without Diabetes
2025 Standout
Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes
2025 Standout
2 intermediate papers

Works of Deborah Hinnen being referenced

Glucagon-Like Peptide 1 Receptor Agonists for Type 2 Diabetes
2017 Standout

Author Peers

Author Last Decade Papers Cites
Deborah Hinnen 784 209 170 24 927
Matthias Axel Schweitzer 1045 267 183 15 1.1k
Ian Peacock 508 178 135 31 958
R. Gentilella 584 199 253 34 879
Roberta Arnoldi Cobas 513 155 158 36 931
Ted Wu 512 154 64 30 778
Siripoom McKay 547 195 162 38 1.0k
Gayle M. Lorenzi 531 244 180 39 1.1k
Nicolae Hâncu 668 212 173 51 1.1k
Eleanor Z. Wallace 493 153 99 36 907
Joan Lee Parkes 764 264 187 36 1.1k

All Works

Loading papers...

Rankless by CCL
2026